These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21161261)

  • 1. EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's disease.
    Painold A; Anderer P; Holl AK; Letmaier M; Saletu-Zyhlarz GM; Saletu B; Bonelli RM
    J Neurol; 2011 May; 258(5):840-54. PubMed ID: 21161261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative EEG mapping studies in Huntington's disease patients and controls.
    Painold A; Anderer P; Holl AK; Letmaier M; Saletu-Zyhlarz GM; Saletu B; Bonelli RM
    J Neural Transm (Vienna); 2010 Nov; 117(11):1307-18. PubMed ID: 20931245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression.
    Saletu B; Anderer P; Saletu-Zyhlarz GM
    Clin EEG Neurosci; 2010 Oct; 41(4):203-10. PubMed ID: 21077572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EEG Functional Connectivity and Cognitive Variables in Premanifest and Manifest Huntington's Disease: EEG Low-Resolution Brain Electromagnetic Tomography (LORETA) Study.
    Delussi M; Nazzaro V; Ricci K; de Tommaso M
    Front Physiol; 2020; 11():612325. PubMed ID: 33391027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
    Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
    Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional localization of abnormal EEG activity in migraine: a low resolution electromagnetic tomography (LORETA) study of migraine patients in the pain-free interval.
    Clemens B; Bánk J; Piros P; Bessenyei M; Veto S; Tóth M; Kondákor I
    Brain Topogr; 2008 Sep; 21(1):36-42. PubMed ID: 18679787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between disease severity and brain electric LORETA tomography in Alzheimer's disease.
    Gianotti LR; Künig G; Lehmann D; Faber PL; Pascual-Marqui RD; Kochi K; Schreiter-Gasser U
    Clin Neurophysiol; 2007 Jan; 118(1):186-96. PubMed ID: 17070733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wake and Sleep EEG in Patients With Huntington Disease: An eLORETA Study and Review of the Literature.
    Piano C; Mazzucchi E; Bentivoglio AR; Losurdo A; Calandra Buonaura G; Imperatori C; Cortelli P; Della Marca G
    Clin EEG Neurosci; 2017 Jan; 48(1):60-71. PubMed ID: 27094758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG power spectra in Huntington's disease: clinical and neuropsychological correlates.
    Bylsma FW; Peyser CE; Folstein SE; Folstein MF; Ross C; Brandt J
    Neuropsychologia; 1994 Feb; 32(2):137-50. PubMed ID: 8190239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-theta border EEG abnormalities in preclinical Huntington's disease.
    Ponomareva N; Klyushnikov S; Abramycheva N; Malina D; Scheglova N; Fokin V; Ivanova-Smolenskaia I; Illarioshkin S
    J Neurol Sci; 2014 Sep; 344(1-2):114-20. PubMed ID: 25015843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain electrical source differences between depressed subjects and healthy controls.
    Korb AS; Cook IA; Hunter AM; Leuchter AF
    Brain Topogr; 2008 Dec; 21(2):138-46. PubMed ID: 18958615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Dimensional Electroencephalographic Changes on Low-Resolution Brain Electromagnetic Tomography (LORETA) During the Sleep Onset Period.
    Park DH; Ha JH; Ryu SH; Yu J; Shin CJ
    Clin EEG Neurosci; 2015 Oct; 46(4):340-6. PubMed ID: 25150221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundamentally altered global- and microstate EEG characteristics in Huntington's disease.
    Faber PL; Milz P; Reininghaus EZ; Mörkl S; Holl AK; Kapfhammer HP; Pascual-Marqui RD; Kochi K; Achermann P; Painold A
    Clin Neurophysiol; 2021 Jan; 132(1):13-22. PubMed ID: 33249251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep-related modifications of EEG connectivity in the sensory-motor networks in Huntington Disease: An eLORETA study and review of the literature.
    Piano C; Imperatori C; Losurdo A; Bentivoglio AR; Cortelli P; Della Marca G
    Clin Neurophysiol; 2017 Jul; 128(7):1354-1363. PubMed ID: 28043770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal patterns of sleep and EEG power distribution during non-rapid eye movement sleep in the sheep model of Huntington's disease.
    Vas S; Nicol AU; Kalmar L; Miles J; Morton AJ
    Neurobiol Dis; 2021 Jul; 155():105367. PubMed ID: 33848636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The default mode network and EEG regional spectral power: a simultaneous fMRI-EEG study.
    Neuner I; Arrubla J; Werner CJ; Hitz K; Boers F; Kawohl W; Shah NJ
    PLoS One; 2014; 9(2):e88214. PubMed ID: 24505434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of the contingent negative variation in Huntington's disease: correlations with clinical features.
    de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
    J Neurol Sci; 2007 Mar; 254(1-2):84-9. PubMed ID: 17300807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.
    Fisher SP; Schwartz MD; Wurts-Black S; Thomas AM; Chen TM; Miller MA; Palmerston JB; Kilduff TS; Morairty SR
    Sleep; 2016 Feb; 39(2):379-91. PubMed ID: 26446107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.
    Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Arnold O; Zeitlhofer J; Saletu B
    J Neurol; 2004 Nov; 251(11):1354-63. PubMed ID: 15592731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.